Keywords: first, patient, dosed, kudos, oral, cancer, agent

First patient dosed with KuDOS' oral cancer agent

Article | 01 August 2005

Print This

KuDOS Pharmaceuticals, a UK drug development company that targets DNA damage sensing and signalling to improve the treatment of cancer, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in